WORCESTER, Mass. - Mustang Bio , Inc. (NASDAQ:MBIO), a biopharmaceutical company engaged in the development of cell therapies for cancer treatment, has announced the pricing of a public offering ...

Relmada purchases Sepranolone, a Phase 2b ready asset, for the treatment of Tourette syndrome (TS) and other compulsion-related conditions from Asarina Pharma AB Phase 2a results signaled improvement ...

The New England Journal of Medicine has published results from the Phase II eNRGy trial for Bizengri (zenocutuzumab), a novel cancer med from Merus. Bizengri is the first approved treatment for people ...

LUND, SE / ACCESS Newswire / February 6, 2025 / Alligator Bioscience (STO:ATORX)FDA feedback validates the clinical development strategy and Phase 3 designFDA feedback confirms that the toxicology pac ...

HelloHero, a leading provider of technology-powered mental health and behavioral care, has secured a multi-million dollar investment package from Decathlon Capital Partners. The funding will enable ...

The United States Postal Service on Wednrsday said it would start accepting packages from China and Hong Kong again, just ...

The U.S. Postal Service will continue accepting incoming international parcels from China and Hong Kong after previously announcing that it would suspend them.

French biotech Valneva has secured marketing approval in the UK for its chikungunya vaccine, Ixchiq (chikungunya vaccine), ...

Move followed US introduction of tariffs on Chinese imports and removal of long-standing duty-exemption rule, but is no ...

Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical-stage biotechnology company pioneering innovative cancer and viral infection treatments, today announced the ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.JzBkOQ-g.js ...